With the signature on 21 September, the IMMUNOCLUSTER-2 capitalisation project continues the excellent results of the previous IMMUNO-CLUSTER of the Interreg Italia – Slovenia 2014-2020 programming period.
IMMUNOCLUSTER-2 project addresses the strengthening of cross-border cooperation to improve the quality of life of the population.
The Lead Partner is Celica, biomedicinski center, d.o.o., which will collaborate together with 5 project partners.
The project started on 1st September 2023. The duration will be 24 months.
More information published on the project page!